Although, since November 2021, the stock largely moved in a range where Rs 780 acted as a stiff resistance while levels above Rs 600 acted as strong support. The stock recently gave a breakout from this range last week to hit a fresh record high of Rs 815.
Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418